The U.S. Food and Drug Administration (FDA) has linked Diamond Shruumz-brand chocolate bars, cones, and gummies to 180 illnesses, 73 hospitalizations, and three potential deaths across 34 states. Despite a nationwide recall initiated in June 2024, the products may still be sold in some retail and online locations, prompting a renewed warning from health officials on Friday. The FDA has recommended the recall of all flavors of Diamond Shruumz-brand products, including their Microdosing Chocolate Bars, Infused Cones, and Micro-Dose and Mega-Dose/Extreme Gummies. These products have been found to contain dangerous compounds, including psilocin, acetylpsilocin, muscimol, and pregabalin, according to FDA testing. People who became ill after consuming Diamond Shruumz-brand products reported severe symptoms such as seizures, central nervous system depression, agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting.
The candy-like appearance of Diamond Shruumz products raises concerns about accidental consumption, particularly among children. The FDA urged parents and caregivers to safely dispose of these items and educate young people about their dangers. The products were widely distributed online and through smoke shops and stores selling cannabidiol (CBD) and delta-8 tetrahydrocannabinol (delta-8 THC). Despite the recall, some retailers continue to stock the products, as they have a long shelf life and may still be available. Consumers are encouraged to report any instances of continued sales to the FDA. Georgia reported the highest number of cases related to Diamond Shruumz products, followed by Texas and North Carolina. The FDA advises consumers to discard any remaining Diamond Shruumz products or return them to the company for a refund. Individuals experiencing symptoms after consuming the products should seek medical attention and contact the Poison Help Line at 1-800-222-1222. Retailers are instructed to remove the products from shelves, secure unsold inventory, and contact the FDA for disposal instructions.
While the FDA investigation has transitioned to post-incident monitoring, authorities emphasize that public awareness remains critical. The FDA stated that consumers should avoid any products marketed as psychoactive or containing mushroom extracts. A list of store names and locations where the recalled products were available for retail sale is included in the recall announcement. The Diamond Shruumz products were marketed as containing psychoactive mushroom blends but were found to contain harmful compounds. The FDA has received reports of individuals experiencing severe symptoms after consuming these products, leading to hospitalizations and potential deaths. Despite the recall, there are concerns that some retailers may still be selling the products, prompting the FDA to issue a renewed warning to the public.
In total, 180 illnesses, 73 hospitalizations, and three potential deaths have been linked to Diamond Shruumz-brand chocolate bars, cones, and gummies across 34 states. The products, including Microdosing Chocolate Bars, Infused Cones, and Micro-Dose and Mega-Dose/Extreme Gummies, have been recalled by the FDA due to the presence of dangerous compounds in them. Symptoms reported by individuals who consumed these products include seizures, central nervous system depression, agitation, abnormal heart rates, and nausea. The candy-like appearance of the products poses a risk of accidental ingestion, particularly among children, prompting the FDA to urge parents and caregivers to dispose of these items safely and educate young people about their dangers.
Diamond Shruumz products were widely distributed online and through various retail channels, including smoke shops and stores selling CBD and delta-8 THC products. Despite the recall, there are reports of some retailers continuing to sell the products, which have a long shelf life and may still be available. Consumers are advised to report any instances of continued sales to the FDA and to discard any remaining Diamond Shruumz products or return them for a refund. Those experiencing symptoms after consuming the products should seek medical attention and contact the Poison Help Line. Retailers are instructed to remove the products from shelves, secure unsold inventory, and contact the FDA for disposal instructions. The FDA emphasizes the importance of public awareness and cautions against consuming any products marketed as psychoactive or containing mushroom extracts.
